Galera Therapeutics

Home » Galera Therapeutics

IPO

Galera Therapeutics

Biopharmaceutical

We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

Symbol

GRTX

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
November 7, 2019

Underwriters
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,CITIGROUP GLOBAL MARKETS INC.

This offering is no longer available

To view the prospectus for Galera Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253